FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
Anticoagulation treatment is a vital component of acute coronary syndrome treatment. Selection of the most efficient and safe drug for the acute coronary syndrome patients without ST elevation (NSTEACS) depends on the strategy of treatment and is in fact a difficult task. Fondaparinux (Arixtra) is a...
Saved in:
| Main Authors: | G. V. Mardaryan, S. A. Abugov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2015-09-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FONDAPARINUX IN THE TREATMENT OF ACUTE CORONARY SYNDROME
by: O. O. Shakhmatova
Published: (2017-05-01) -
THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01) -
Parenteral anticoagulants in the treatment of acute coronary syndrome: what modern clinical guidelines say
by: I. S. Yavelov
Published: (2022-06-01) -
FONDAPARINUX IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION – JUSTIFICATION FOR USING AND REAL CLINICAL PRACTICE
by: A. D. Erlikh
Published: (2018-05-01) -
EARLY DISCONTINUATION OF FONDAPARINUX IN LOW-RISK PATIENTS HOSPITALIZED WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: MARKERS OF HEMOSTASIS ACTIVATION AND IN-HOSPITAL OUTCOMES
by: I. S. Yavelov, et al.
Published: (2015-03-01)